Press release

SES Successfully Prices €650 million of SPACE Hybrid Securities

LUXEMBOURG–(BUSINESS WIRE)–NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN, OR AT…

Read More »

INVESTOR ALERT: Securities Class Action Filed Against Grocery Outlet Holding Corp. – Investors Encouraged to Contact Kirby McInerney LLP

NEW YORK–(BUSINESS WIRE)–The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf…

Read More »

Infinity Natural Resources Announces Pricing of Upsized Offering of $550 Million of 7.625% Senior Notes due 2031

MORGANTOWN, W. Va.–(BUSINESS WIRE)–Infinity Natural Resources, Inc. (“Infinity” or the “Company”) (NYSE: INR) today announced that its subsidiary, Infinity Natural…

Read More »

Rimini Street Announces Participation in the ROTH Capital Partners 38th Annual Investor Conference

LAS VEGAS–(BUSINESS WIRE)–Rimini Street, Inc. (Nasdaq: RMNI), a global provider of end-to-end enterprise software support, managed services and Agentic AI…

Read More »

Research Quest Celebrates 10-Year Anniversary and 1 Million Learning Sessions  

Museum-Built Resource Used by Teachers Worldwide SALT LAKE CITY–(BUSINESS WIRE)–The Natural History Museum of Utah’s (NHMU) free, award‑winning online educator…

Read More »

Verastem Oncology Announces Abstracts Accepted for Presentation on AVMAPKI™ FAKZYNJA™ (avutometinib capsules; defactinib tablets) Combination Therapy at the Society of Gynecologic Oncology 2026 Annual Meeting on Women’s Cancers

Plenary oral presentation features long-term follow-up data from the Phase 2 RAMP 201 recurrent low-grade serous ovarian cancer clinical trial…

Read More »

JPMorganChase to Host First-Quarter 2026 Earnings Call

NEW YORK–(BUSINESS WIRE)–As previously announced, JPMorgan Chase & Co. (NYSE: JPM) (“JPMorganChase” or the “Firm”) will host a conference call…

Read More »

Fifth Third Bancorp Announces Cash Dividends

CINCINNATI–(BUSINESS WIRE)–Today, Fifth Third Bancorp announced the declaration of cash dividends on its common shares, Series H preferred shares, Series…

Read More »

Agenus Announces Upcoming AACR 2026 Presentation Evaluating Botensilimab Plus Balstilimab in First-Line MSS Metastatic Colorectal Cancer

A novel, chemo-sparing strategy (BBoPCO): introducing BOT+BAL in 1L MSS mCRC to extend survival and reduce use of cytotoxic chemotherapy…

Read More »

Zai Lab to Present New Data on Three Internally Developed Oncology Candidates at AACR 2026, Including Zocilurtatug Pelitecan, a DLL3-Targeting Antibody-Drug Conjugate (ADC)

– Zoci data show intracranial response in small-cell lung cancer (SCLC) with brain metastases, as well as activity in other…

Read More »